{"skill":{"slug":"curevac-nv","displayName":"Curevac Nv","summary":"德国图宾根mRNA技术先锋，专注肿瘤免疫和罕见病，曾开发新冠疫苗CVnCoV，拥有20年mRNA研究积累。","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":99,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1778267234363,"updatedAt":1778492880688},"latestVersion":{"version":"1.0.0","createdAt":1778267234363,"changelog":"- 首发版本，介绍CureVac公司及其发展历程  \n- 覆盖历史时间线、商业模式、护城河和关键运营数据  \n- 明确CureVac在mRNA领域的技术积累与行业定位  \n- 针对肿瘤免疫和罕见病赛道的最新战略转型  \n- 增加与BioNTech、Moderna异同和有趣历史事实","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}